Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kristina E. Hoot, Jessyka Lighthall, Gangwen Han, Shi-Long Lu, Allen Li, Wenjun Ju, Molly Kulesz-Martin, Erwin Bottinger, Xiao-Jing Wang
Published in Volume 118, Issue 8
J Clin Invest. 2008; 118(8):2722–2732 doi:10.1172/JCI33713
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Reduced mRNA and LOH of Smad2 and Smad4 in human skin SCCs.

(A) qRT-PCR of 33 human skin SCCs showed loss of Smad2 (31/33 samples) and Smad4 (28/33 samples) expression compared with normal skin controls. The inset shows the mean value for control and skin SCC. **P < 0.001. (B) LOH of Smad2 and Smad4 in human SCCs. Microsatellite markers D18S1137 and D18S555 were used to assess Smad2 LOH, and D18S46 and D18S1110 were used to assess Smad4 LOH. Het, heterozygosity; Noninformative, adjacent tissue exhibited homozygosity.